BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200825T103000
DTEND;TZID=America/New_York:20200825T114500
DTSTAMP:20260610T093006
CREATED:20200817T132110Z
LAST-MODIFIED:20200819T143706Z
UID:4254-1598351400-1598355900@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: AMR pull incentives | Will COVID-19 speed up or slow down implementation?
DESCRIPTION:Moderator:  \n\nKathy Talkington\, Director Health Programs\, Pew Charitable Trust\n\nSpeakers: \n\nColm Leonard – Clinical Advisor/Consultant\, NICE\nKevin Outterson – Professor of Law & Executive Director\, CARB-X\nElmar Nimmesgern – Secretariat Lead\, Global AMR R&D Hub\nDaniel Berman – Lead of the Global Health Team\, Longitude Prize / Nesta
URL:https://carb-x.org/event/biocom-4th-amr-conference-amr-pull-incentives-will-covid-19-speed-up-or-slow-down-implementation/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200825T091500
DTEND;TZID=America/New_York:20200825T101500
DTSTAMP:20260610T093006
CREATED:20200817T131812Z
LAST-MODIFIED:20200819T143409Z
UID:4250-1598346900-1598350500@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: Business models in AMR | How to develop strategic decisions in a challenging and global AMR market
DESCRIPTION:Moderator:  \n\nGökhan Batur – CEO\, Polyphor Ltd\n\nSpeakers: \n\nPeter Beyer – Senior Advisor Department of Essential Medicines & Health Products\, WHO\nErin Duffy – Chief of Research & Development\, CARB-X\nHolger Zimmermann – CEO\, AiCuris
URL:https://carb-x.org/event/biocom-4th-amr-conference-sme-approach-how-to-develop-strategic-decisions-in-a-challenging-and-global-amr-market/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200824
DTEND;VALUE=DATE:20200829
DTSTAMP:20260610T093006
CREATED:20200214T152647Z
LAST-MODIFIED:20200824T153930Z
UID:3796-1598227200-1598659199@carb-x.org
SUMMARY:BIOCOM 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics
DESCRIPTION:This year’s digital AMR Conference will be an international forum to discuss AMR in the context of COVID-19 and beyond. \nCARB-X speakers include Kevin Outterson\, Executive Director\, Erin Duffy\, Chief of Research and Development\, and Betsy Wonderly Trainor\, Alliance Director. \nThe current global health crisis caused by COVID-19 shows more than ever the importance of infectious diseases expertise and the high need for further fighting against antimicrobial resistance (AMR). A cross-sectoral international dialogue with all stakeholders involved will be crucial to help implement innovative therapies and diagnostics in the clinical practice globally. \nTogether with our supporters – among others our major partner\, the BEAM Alliance – the AMR Conference will continue to provide a (virtual) platform for those debates bringing together stakeholders from industry\, SMEs\, start-ups\, academia\, clinics\, investors\, public institutions and policy. Within our digital AMR Conference Week in August\, we want to catch up discussing the challenges of bringing new antimicrobial treatments and diagnostics into the market and as a result\, help to establish a post-COVID policy roadmap on AMR. \nFive days of insights and networking for the global AMR community: Each conference day will cover a focus topic with selected LIVE sessions and high-level panels. Additionally\, you will be able to explore scientific poster presentations and participate in virtual 1:1 meetings throughout the whole week and to engage within our new digital AMR stakeholder platform which is currently being set up. \n\n\n\n\n\nClick here to view the programme.\nClick here to learn more.\nClick here to register.
URL:https://carb-x.org/event/biocom-4th-amr-conference-novel-antimicrobials-and-amr-diagnostics/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200807T100000
DTEND;TZID=America/New_York:20200807T150000
DTSTAMP:20260610T093006
CREATED:20200720T163544Z
LAST-MODIFIED:20200720T163544Z
UID:4158-1596794400-1596812400@carb-x.org
SUMMARY:Longitude Prize Sprint Workshop 1 - Navigating MedTech Regulation Pathways in Developed and Emerging Markets
DESCRIPTION:In July 2020\, the Longitude Prize is launching the Longitude Prize Sprint Programme. The Sprint programme is free and will consist of a mix of Sprint Workshops and Sprint 1:1 Expert Support and is perfect for people and teams working in the field of AMR diagnostic test development. The Longitude Prize will be running three Sprint Workshop webinars from July to November 2020. The Sprint Workshops (virtual webinars) are open to all Longitude Prize Competitors\, along with diagnostic test developers who are looking for technical advice and support for regulatory pathways\, finance and investment\, and manufacture and distribution strategies.\n\n\nLongitude Prize Sprint Workshop 1 – Navigating MedTech Regulation Pathways in Developed and Emerging Markets \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMedtech product development and commercialisation for devices and diagnostics is a complex process and has a long gestation period. There are many uncertainties that Medtech product development has to navigate especially during technology development and validation stages of product development as well as being able to meet regulatory standards. Successful navigation of the regulatory maze is important in product development roadmap. \nThere are subtle and distinct variations in regulatory standards for Medtech products across different geographies especially between developed and developing countries. Another layer of complexity is the continuous change in regulatory landscapes both in mature and evolving markets across the world. \nThe workshop (virtual webinar)\, as part of the Longitude Prize Sprint programme\, will draw upon insights from experts in Medtech regulation and address the nuances of regulation in different geographies which will guide Medtech companies in their product development strategies. \n\nTo learn more\, click here. 
URL:https://carb-x.org/event/longitude-prize-sprint-workshop-1-navigating-medtech-regulation-pathways-in-developed-and-emerging-markets/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200625T110000
DTEND;TZID=America/New_York:20200625T121500
DTSTAMP:20260610T093006
CREATED:20200601T144452Z
LAST-MODIFIED:20200601T144452Z
UID:4059-1593082800-1593087300@carb-x.org
SUMMARY:JLABS Webinar: Raising Capital: A Legal Primer
DESCRIPTION:Having a clear strategy for raising growth capital and understanding the evolution and dynamic of investment deals are essential for the long-term health of your business. Join JLABS\, Allen & Overy and O’Melveny to learn more and discuss key issues such as: \n\nKey points in growth capital deals\nEvolution of deal dynamics\nBoard seats\nGovernance structure\nEconomic terms\nExit terms\n\nTo learn more\, click here.\n\nThis program is part of the Johnson & Johnson Innovation – JLABS Legal Webinar Series for life science entrepreneurs\, together with Allen & Overy and O’Melveny. You can register for other webinars in the series by visiting this page.
URL:https://carb-x.org/event/jlabs-webinar-raising-capital-a-legal-primer/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200609T120000
DTEND;TZID=America/New_York:20200609T130000
DTSTAMP:20260610T093006
CREATED:20200601T144305Z
LAST-MODIFIED:20200601T144305Z
UID:4058-1591704000-1591707600@carb-x.org
SUMMARY:JLABS Webinar: Pulse Check-Today's Funding Landscape
DESCRIPTION:Today’s current crisis has changed the mindset of many industry strategic partners\, investors and overall stakeholders. From pivoting investment priorities\, to identifying new areas of innovation\, the investor landscape is constantly shifting. \nFor small to medium sized biotechs\, it can be hard to keep up with promised milestones while also planning and anticipating the future of their companies. How could companies be preparing for not only the short-term but for years to come? What should be prioritized in the coming months? Who is still investing? How can they find the right partners for them as they move forward? \nJoin JLABS as we welcome members of Johnson and Johnson Development Corp.\, and other industry investors to: \n\n\n\n\n\n\n\n\n\nShare how they are planning for the future and pivoting in the current crisis\nWhat they believe companies should be prioritizing\nHow bio-techs could stay connected with their current and potential stakeholders\nWhere they could find the right resources and investment opportunities\, and overall gain a pulse check on the investor community\n\nTo learn more\, click here.
URL:https://carb-x.org/event/jlabs-webinar-pulse-check-todays-funding-landscape/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200529T100000
DTEND;TZID=America/New_York:20200529T113000
DTSTAMP:20260610T093006
CREATED:20200527T163340Z
LAST-MODIFIED:20200527T163340Z
UID:4052-1590746400-1590751800@carb-x.org
SUMMARY:Live Webinar: o2h ventures 6th ChaiTime Webinar Registration
DESCRIPTION:Join us on Friday\, May 29 @ 3:00 PM BST (10:00 AM EST / 7.30 PM IST) for our the sixth o2h ventures ChaiTime webinar on ‘Antibiotic Resistance – The fight for humanity’. \nErin Duffy\, Chief of R&D\, CARB-X \, will chair the 6th o2h ventures ChaiTime discussion on drug resistance and lessons to be learned fron the COVID-19 pandemic. \nClick Here to Register for the Webinar. \nWebinar Chair: \nErin Duffy\, Chief of R&D @ CARB-X \nPanelists and Speakers: \nKen Bradley\, Global Head\, Infectious Disease Discovery at Roche pharmaceutical Research and Early Development (pRED) \nAnkit Mahadevia\, CEO of NASDAQ listed\, Spero Therapeutics \nPaul Finn\, CEO of Oxford University Spinout\, Oxford Drug Design \nAjay Mistry\, CEO of AI and antibiotics discovery start-up\, Oppilotech
URL:https://carb-x.org/event/live-webinar-o2h-ventures-6th-chaitime-webinar-registration/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180626T110000
DTEND;TZID=America/New_York:20180626T123000
DTSTAMP:20260610T093006
CREATED:20180621T135932Z
LAST-MODIFIED:20180621T135932Z
UID:1585-1530010800-1530016200@carb-x.org
SUMMARY:GARDP Live Discussion Webinar: PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?
DESCRIPTION:
URL:https://carb-x.org/event/gardp-live-discussion-webinar-pk-pd-in-support-of-accelerated-programmes-for-antimicrobial-development-how-much-is-enough/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20180613T173000
DTEND;TZID=Europe/Berlin:20180613T183000
DTSTAMP:20260610T093006
CREATED:20180607T153252Z
LAST-MODIFIED:20180607T153501Z
UID:1549-1528911000-1528914600@carb-x.org
SUMMARY:Webinar: Antibacterial Drugs: Clinical Development for Non-Developers Part 1 'Traditional development - tiers A and B
DESCRIPTION:
URL:https://carb-x.org/event/antibacterial-drugs-clinical-development-for-non-developers-part-1-traditional-development-tiers-a-and-b/
LOCATION:Webinar
END:VEVENT
END:VCALENDAR